Effetti della prostaglandina PGE1 alfa-ciclodestrina sul microcircolo cutaneo. Valutazione flussimetrica e termografica

Translated title of the contribution: Effects of prostaglandin PGE1 on cutaneous microcirculation. Flowmeter and thermographic assessment

F. Distante, E. Berardesca, L. Miori, G. Rabbiosi

Research output: Contribution to journalArticle

Abstract

Background. In this study, the efficacy of PGE1 therapy was evaluated to improve cutaneous microcirculation in patient suffering from progressive systemic sclerosis (PSS) and Raynaud's phenomenon and from chronic ischemic wounds of legs. Methods. Sixteen subjects were included in the trial; 13 of them were suffering from PSS and Raynaud's phenomenon; 3 of them from ischemic ulcers of legs. The subjects were treated with 60 μg/die of PGE1 alpha-ciclodestrin in saline intravenous infusion. Cutaneous microcirculation was assessed by means of contact thermography with image analysis and laser Doppler flowmeter with reactive hyperemic test. From the analysis of this test, baseline skin blood flow, the area under the curve of maximal vasodilatation (AUC) and the maximal hyperemic response (max peak) was calculated. Results. The results show a statistically significant increase of limb skin temperature, of AUC and maximal hyperemic response values. Baseline mean flux values, though increased, were not statistically significantly changed. Conclusions. The conclusion is drawn that PGE1 can be an effective support in cutaneous vascular disease therapy. The mechanism of action of this compound could be related to an improvement of microcirculation modulation in response to neurovegetative triggers.

Original languageItalian
Pages (from-to)67-72
Number of pages6
JournalGiornale Italiano di Dermatologia e Venereologia
Volume134
Issue number1
Publication statusPublished - 1999

Fingerprint

Flowmeters
Alprostadil
Microcirculation
Area Under Curve
Prostaglandins
Diffuse Scleroderma
Raynaud Disease
Skin
Leg Ulcer
Skin Temperature
Skin Tests
Vascular Diseases
Skin Diseases
Intravenous Infusions
Vasodilation
Leg
Lasers
Extremities
Wounds and Injuries
Therapeutics

ASJC Scopus subject areas

  • Dermatology

Cite this

Effetti della prostaglandina PGE1 alfa-ciclodestrina sul microcircolo cutaneo. Valutazione flussimetrica e termografica. / Distante, F.; Berardesca, E.; Miori, L.; Rabbiosi, G.

In: Giornale Italiano di Dermatologia e Venereologia, Vol. 134, No. 1, 1999, p. 67-72.

Research output: Contribution to journalArticle

@article{fe9fe1d7c3144726b08faa34668d315f,
title = "Effetti della prostaglandina PGE1 alfa-ciclodestrina sul microcircolo cutaneo. Valutazione flussimetrica e termografica",
abstract = "Background. In this study, the efficacy of PGE1 therapy was evaluated to improve cutaneous microcirculation in patient suffering from progressive systemic sclerosis (PSS) and Raynaud's phenomenon and from chronic ischemic wounds of legs. Methods. Sixteen subjects were included in the trial; 13 of them were suffering from PSS and Raynaud's phenomenon; 3 of them from ischemic ulcers of legs. The subjects were treated with 60 μg/die of PGE1 alpha-ciclodestrin in saline intravenous infusion. Cutaneous microcirculation was assessed by means of contact thermography with image analysis and laser Doppler flowmeter with reactive hyperemic test. From the analysis of this test, baseline skin blood flow, the area under the curve of maximal vasodilatation (AUC) and the maximal hyperemic response (max peak) was calculated. Results. The results show a statistically significant increase of limb skin temperature, of AUC and maximal hyperemic response values. Baseline mean flux values, though increased, were not statistically significantly changed. Conclusions. The conclusion is drawn that PGE1 can be an effective support in cutaneous vascular disease therapy. The mechanism of action of this compound could be related to an improvement of microcirculation modulation in response to neurovegetative triggers.",
keywords = "Laser Doppler flowmetry, Microcirculation, Prostaglandins therapeutic use, Scleroderma, systemic, Skin blood supply, Thermography",
author = "F. Distante and E. Berardesca and L. Miori and G. Rabbiosi",
year = "1999",
language = "Italian",
volume = "134",
pages = "67--72",
journal = "Minerva dermatologica",
issn = "0392-0488",
publisher = "Edizioni Minerva Medica S.p.A.",
number = "1",

}

TY - JOUR

T1 - Effetti della prostaglandina PGE1 alfa-ciclodestrina sul microcircolo cutaneo. Valutazione flussimetrica e termografica

AU - Distante, F.

AU - Berardesca, E.

AU - Miori, L.

AU - Rabbiosi, G.

PY - 1999

Y1 - 1999

N2 - Background. In this study, the efficacy of PGE1 therapy was evaluated to improve cutaneous microcirculation in patient suffering from progressive systemic sclerosis (PSS) and Raynaud's phenomenon and from chronic ischemic wounds of legs. Methods. Sixteen subjects were included in the trial; 13 of them were suffering from PSS and Raynaud's phenomenon; 3 of them from ischemic ulcers of legs. The subjects were treated with 60 μg/die of PGE1 alpha-ciclodestrin in saline intravenous infusion. Cutaneous microcirculation was assessed by means of contact thermography with image analysis and laser Doppler flowmeter with reactive hyperemic test. From the analysis of this test, baseline skin blood flow, the area under the curve of maximal vasodilatation (AUC) and the maximal hyperemic response (max peak) was calculated. Results. The results show a statistically significant increase of limb skin temperature, of AUC and maximal hyperemic response values. Baseline mean flux values, though increased, were not statistically significantly changed. Conclusions. The conclusion is drawn that PGE1 can be an effective support in cutaneous vascular disease therapy. The mechanism of action of this compound could be related to an improvement of microcirculation modulation in response to neurovegetative triggers.

AB - Background. In this study, the efficacy of PGE1 therapy was evaluated to improve cutaneous microcirculation in patient suffering from progressive systemic sclerosis (PSS) and Raynaud's phenomenon and from chronic ischemic wounds of legs. Methods. Sixteen subjects were included in the trial; 13 of them were suffering from PSS and Raynaud's phenomenon; 3 of them from ischemic ulcers of legs. The subjects were treated with 60 μg/die of PGE1 alpha-ciclodestrin in saline intravenous infusion. Cutaneous microcirculation was assessed by means of contact thermography with image analysis and laser Doppler flowmeter with reactive hyperemic test. From the analysis of this test, baseline skin blood flow, the area under the curve of maximal vasodilatation (AUC) and the maximal hyperemic response (max peak) was calculated. Results. The results show a statistically significant increase of limb skin temperature, of AUC and maximal hyperemic response values. Baseline mean flux values, though increased, were not statistically significantly changed. Conclusions. The conclusion is drawn that PGE1 can be an effective support in cutaneous vascular disease therapy. The mechanism of action of this compound could be related to an improvement of microcirculation modulation in response to neurovegetative triggers.

KW - Laser Doppler flowmetry

KW - Microcirculation

KW - Prostaglandins therapeutic use

KW - Scleroderma, systemic

KW - Skin blood supply

KW - Thermography

UR - http://www.scopus.com/inward/record.url?scp=0032960095&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032960095&partnerID=8YFLogxK

M3 - Articolo

VL - 134

SP - 67

EP - 72

JO - Minerva dermatologica

JF - Minerva dermatologica

SN - 0392-0488

IS - 1

ER -